Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on Rituximab for Reducing Steroid Use in Newly Diagnosed Polymyalgia Rheumatica Patients
The NetherlandsStudy on the Effects of Abiprubart for Patients with Sjögren’s Disease
CzechiaStudy on the Effectiveness and Safety of Cyclosporine and Methotrexate for Children and Adolescents with Moderate to Severe Atopic Dermatitis
PolandStudy on the Effectiveness of Doravirine and Dolutegravir for People with HIV Switching Antiretroviral Therapy
ItalyStudy on the Safety and Effectiveness of tolDC for Patients with Relapsing Remitting and Progressive Multiple Sclerosis
BelgiumStudy on the Use of Flutemetamol (18F) for Diagnosing Cardiac Amyloidosis in Patients
ItalyStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
BelgiumStudy on FX06 for Improving Acute Respiratory Distress Syndrome in Patients
FranceStudy of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease
BelgiumStudy on Tezepelumab for Patients with Severe Asthma
FranceStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
